Health Catalyst マネジメント
マネジメント 基準チェック /34
Health Catalystの CEO はDan Burtonで、 Oct2012年に任命され、 の在任期間は 12.08年です。 は、会社の株式の1.42%を直接所有しており、その価値は$ 6.36M 。経営陣と取締役会の平均在任期間はそれぞれ2.2年と7.5年です。
主要情報
Dan Burton
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | 12.1yrs |
| CEOの所有権 | 1.4% |
| 経営陣の平均在職期間 | 2.2yrs |
| 取締役会の平均在任期間 | 7.5yrs |
経営陣の近況
Recent updates
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17
Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Dec 06Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Oct 14Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer
Sep 07CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$79m |
| Jun 30 2024 | n/a | n/a | -US$86m |
| Mar 31 2024 | n/a | n/a | -US$106m |
| Dec 31 2023 | n/a | n/a | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$124m |
| Jun 30 2023 | n/a | n/a | -US$147m |
| Mar 31 2023 | n/a | n/a | -US$148m |
| Dec 31 2022 | US$4m | US$150k | -US$137m |
| Sep 30 2022 | n/a | n/a | -US$151m |
| Jun 30 2022 | n/a | n/a | -US$145m |
| Mar 31 2022 | n/a | n/a | -US$147m |
| Dec 31 2021 | US$6m | US$300k | -US$153m |
| Sep 30 2021 | n/a | n/a | -US$147m |
| Jun 30 2021 | n/a | n/a | -US$135m |
| Mar 31 2021 | n/a | n/a | -US$126m |
| Dec 31 2020 | US$5m | US$315k | -US$115m |
| Sep 30 2020 | n/a | n/a | -US$86m |
| Jun 30 2020 | n/a | n/a | -US$99m |
| Mar 31 2020 | n/a | n/a | -US$181m |
| Dec 31 2019 | US$4m | US$350k | -US$241m |
| Sep 30 2019 | n/a | n/a | -US$304m |
| Jun 30 2019 | n/a | n/a | -US$282m |
| Mar 31 2019 | n/a | n/a | -US$190m |
| Dec 31 2018 | US$5m | US$315k | -US$114m |
報酬と市場: Danの 総報酬 がUS市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。
報酬と収益: Danの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Dan Burton (49 yo)
12.1yrs
在職期間
Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 12.1yrs | データなし | 1.42% $ 6.4m | |
| Chief Financial Officer | less than a year | US$823.62k | 0.19% $ 839.8k | |
| General Counsel & Secretary of the Board | 1.5yrs | US$946.31k | 0.17% $ 742.9k | |
| Chief People Officer | 6.8yrs | US$1.06m | 0.029% $ 128.1k | |
| Chief Operating Officer | less than a year | データなし | 0.051% $ 230.0k | |
| Chief Technology Officer | 2.2yrs | データなし | データなし | |
| Senior Vice President of Investor Relations and Financial Planning & Analysis | 3.8yrs | データなし | データなし | |
| Senior Vice President of Marketing & Communications | less than a year | データなし | データなし | |
| Chief Strategy Officer & Senior VP of Corporate Development | no data | データなし | データなし | |
| Senior Vice President of International | 5.5yrs | データなし | データなし | |
| Senior VP & Chief Clinical Officer | no data | データなし | データなし | |
| Chief Client Success Officer | no data | データなし | データなし |
2.2yrs
平均在職期間
46yo
平均年齢
経験豊富な経営陣: HCATの経営陣は 経験豊富 であると考えられます ( 2.2年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 13.2yrs | データなし | 1.42% $ 6.4m | |
| Independent Chairman | 8.8yrs | US$316.16k | 0.18% $ 811.0k | |
| Independent Director | 4.8yrs | US$233.49k | 0.076% $ 341.3k | |
| Independent Director | 4.8yrs | US$237.25k | 0.073% $ 328.7k | |
| Independent Director | 8.6yrs | US$244.77k | 0.058% $ 261.3k | |
| Independent Director | 7.5yrs | US$244.77k | 0.092% $ 413.1k | |
| Independent Director | 1.3yrs | データなし | データなし |
7.5yrs
平均在職期間
60yo
平均年齢
経験豊富なボード: HCATの 取締役会 は 経験豊富 であると考えられます ( 7.5年の平均在任期間)。